Aduro Biotech Inc.

ADRO

7.85

-0.10

-1.3%

After Hours:

7.85

0.00

0.0%

Please Login or Register

Login|Register FREE

Stock Price
Open: 7.95
Prev. Close: 7.95
Low/Hi: 7.80 - 8.10
52-Week: 5.82 - 14.05
Volumes
Equity: 185,966
90-Day Avg: 543,821
Option: 27
90-Day Avg: 67
Volatility
Todays Stock Vol: 29.4
20-Day (HV): 45.7
52-Week (HV): 59.2
30-Day IV: 66.0 -4.3
IV Pct Rank: 0% Subdued
Fundamental
Div. Yield:
Earnings: 2-Aug (Est.)
P/E Ratio:
Market Cap: 625.9 M
Short Int Pct: 0.0%
Pct Held By Inst.: 69.4%
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

About ADRO

Aduro Biotech, Inc. is a clinical-stage immuno-oncology company focused on the development of technology platforms to stimulate an immune response against cancer. Aduros lead platform is based on proprietary strains of live-attenuated, double-deleted (LADD) Listeria monocytogenes that induce a potent innate immune response and have been engineered to express tumor-associated antigens to induce tumor-specific T cell-mediated immunity. Aduro has received Breakthrough Therapy designation from the FDA for its lead LADD regimen, CRS-207 in combination with GVAX Pancreas in pancreatic cancer. The company is evaluating the proprietary immuno-oncology combination in the ongoing Phase 2b ECLIPSE clinical trial and has additional ongoing clinical trials with its LADD platform in mesothelioma and glioblastoma. The company is also developing clinical candidates using cyclic dinucleotide (CDN) synthetic small molecule immune modulators that are designed to activate the intracellular STING receptor, a central mediator of the innate immune response.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ADRO is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 362.1 M 3.62084E+08 203 203 0.04% 0.000354403 271 K 270713
EQWS PowerShares Russell 2000 Equal Weight Portfolio 25.0 M 2.5E+07 1,927 1927 0.03% 0.00031 8 K 7831
FHLC Fidelity MSCI Health Care Index ETF 1.1 B 1.1E+09 338 338 0.01% 7.18409E-05 78 K 78336
IBB iShares Nasdaq Biotechnology Index Fund 9.0 B 8.96125E+09 192 192 0.08% 0.0008 7.4 M 7420360
ITOT iShares Core S&P Total U.S. Stock Market ETF 13.8 B 1.37811E+10 3,460 3460 0.0% 0 98 K 98286
IWM iShares Russell 2000 ETF 45.9 B 4.58636E+10 1,975 1975 0.02% 0.0002 7.2 M 7211650
IWO iShares Russell 2000 Growth ETF 10.3 B 1.02907E+10 1,183 1183 0.03% 0.0003 3.1 M 3113480
IWV iShares Russell 3000 ETF 8.4 B 8.39591E+09 2,930 2930 0.0% 0 77 K 76519
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.7 B 1.7E+09 981 981 0.01% 0.000104844 182 K 181711
SBIO ALPS Medical Breakthroughs ETF 192.1 M 1.92065E+08 97 97 0.41% 0.0041 787 K 787466
UBIO Proshares UltraPro Nasdaq Biotechnology 38.1 M 3.80733E+07 197 197 0.02% 0.000209933 26 K 25575
URTY ProShares UltraPro Russell2000 151.0 M 1.51024E+08 1,985 1985 0.0% 3.17316E-05 16 K 16019
UWM ProShares Ultra Russell2000 238.4 M 2.38449E+08 1,985 1985 0.01% 5.80541E-05 31 K 30544
VB Vanguard Small-Cap ETF 21.7 B 2.17E+10 1,436 1436 0.01% 8E-05 1.8 M 1822050
VBK Vanguard Small-Cap Growth ETF 7.5 B 7.5E+09 676 676 0.02% 0.00019 1.4 M 1395800
VHT Vanguard Health Care ETF 7.1 B 7.1E+09 362 362 0.01% 7E-05 467 K 466608
VTHR Vanguard Russell 3000 ETF 352.7 M 3.527E+08 2,725 2725 0.0% 1E-05 4 K 3944
VTI Vanguard Total Stock Market ETF 93.3 B 9.33E+10 3,629 3629 0.0% 1E-05 983 K 983285
VTWG Vanguard Russell 2000 Growth ETF 249.3 M 2.493E+08 1,205 1205 0.03% 0.00028 70 K 69936
VTWO Vanguard Russell 2000 ETF 1.3 B 1.3E+09 2,003 2003 0.01% 0.00014 188 K 187858
VXF Vanguard Extended Market ETF 5.9 B 5.9E+09 3,259 3259 0.01% 5E-05 302 K 302412

Wait, Before You Leave...

Want to Know More About ADRO Earnings?

Receive your FREE email to get Wall Street expected earnings moves and daily upcoming earnings alerts!
Market Chameleon